Reference health

Synthesis, characterization, biological activity, DNA and BSA binding study: novel copper( <scp>ii</scp> ) complexes with 2-hydroxy-4-aryl-4-oxo-2-butenoate

https://doi.org/10.1039/c6dt02257j
CiteStamped reference-health badge
81/81 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 81 checked references that resolve
resolves10.1016/S0898-8838(08)60035-5
Inorganic Chemistry and Drug Design
resolves10.1016/j.ccr.2006.11.017
Using coordination chemistry to design new medicines
resolves10.1039/b705551j
Metal based drugs: from serendipity to design
resolves10.1039/b706075k
Developing new metal-based therapeutics: challenges and opportunities
resolves10.1002/9783906390420
Cisplatin
resolves10.2174/092986706776872970
Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin
resolves10.1007/s11243-012-9613-4
Cytotoxic properties of platinum(IV) and dinuclear platinum(II) complexes and their ligand substitution reactions with guanosine-5′-monophosphate
resolves10.1023/A:1006490226104
A Randomized Trial Comparing the Nephrotoxicity of Cisplatin/Ifosfamide-Based Combination Chemotherapy with or without Amifostine in Patients with Solid Tumors
resolves10.1517/14656566.4.6.889
Toxicity of platinum compounds
resolves10.1080/08880010590964381
SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
resolves10.3390/toxins2112490
Mechanisms of Cisplatin Nephrotoxicity
resolves10.1158/1535-7163.MCT-08-0840
Platinum neurotoxicity pharmacogenetics
resolves10.1002/ardp.200600151
Non Platinum Metal Complexes as Anti‐cancer Drugs
resolves10.1021/jm040763n
Development of Cobalt(3,4-diarylsalen) Complexes as Tumor Therapeutics
resolves10.2174/157340612799278469
Cytotoxicity of gold(III) Complexes on A549 Human Lung Carcinoma Epithelial Cell Line
resolves10.1039/C4CS00063C
Anti-cancer palladium complexes: a focus on PdX <sub>2</sub> L <sub>2</sub> , palladacycles and related complexes
resolves10.1039/C5DT04132E
DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium( <scp>ii</scp> ) terpyridine complexes
resolves10.1039/c3sc22294b
Novel metal(ii) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents
resolves10.1039/C3SC53243G
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
resolves10.1039/c4sc00116h
Conformational control of anticancer activity: the application of arene-linked dinuclear ruthenium(ii) organometallics
resolves10.1039/c2sc01031c
Osmium(vi) nitrido complexes bearing azole heterocycles: a new class of antitumor agents
resolves10.1039/c2sc20220d
The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium(ii) arene anticancer complexes
resolves10.1039/b707440a
Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives
resolves10.1039/C5SC01955A
Cyclometalated iridium( <scp>iii</scp> ) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents
resolves10.1039/c2sc00620k
Anticancer dirhodium(ii,ii) carboxylates as potent inhibitors of ubiquitin-proteasome system
resolves10.1016/j.ccr.2007.12.026
Antiproliferative and anti-tumor activity of organotin compounds
resolves10.1039/C4SC00384E
A mitochondrion-targeting copper complex exhibits potent cytotoxicity against cisplatin-resistant tumor cells through multiple mechanisms of action
resolves10.1002/med.20174
Copper in diseases and treatments, and copper‐based anticancer strategies
resolves10.2174/187152009787313837
Copper Complexes as Anticancer Agents
resolves10.1021/cr400135x
Advances in Copper Complexes as Anticancer Agents
resolves10.1007/s00418-006-0183-4
Non-apoptotic programmed cell death induced by a copper(II) complex in human fibrosarcoma cells
resolves10.1016/S0162-0134(02)00545-7
Synthesis, molecular structure, solution equilibrium, and antiproliferative activity of thioxotriazoline and thioxotriazole complexes of copper(II) and palladium(II)
resolves10.1016/S0162-0134(99)00131-2
Cytotoxicity of salicylaldehyde benzoylhydrazone analogs and their transition metal complexes: quantitative structure–activity relationships
resolves10.1016/j.ejmech.2010.08.060
Crystal structures, DNA-binding and cytotoxic activities studies of Cu(II) complexes with 2-oxo-quinoline-3-carbaldehyde Schiff-bases
resolves10.5767/anurs.cmat.100102.en.133J
ANTICANCER ACTIVITY OF NEW COPPER(II) COMPLEXES INCORPORATING A PYRIDOXAL-SEMICARBAZONE LIGAND
resolves10.1016/j.ejmech.2016.03.003
Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings
resolves10.1039/c3dt50371b
Potentially cytotoxic new copper(ii) hydrazone complexes: synthesis, crystal structure and biological properties
resolves10.4314/bcse.v24i3.60680
&lt;b&gt;Synthesis, characterisation and antimicrobial activities of cobalt(II), copper(II) and zinc(II) mixed-ligand complexes containing 1,10-phenanthroline and 2,2’-bipyridine&lt;/b&gt;
resolves10.1016/j.jscs.2011.04.007
Synthesis, characterization and antimicrobial activities of copper complexes derived from 4-aminoantipyrine derivatives
resolves10.1016/j.ica.2013.06.029
Crystal structures and antimicrobial activities of copper(II) complexes of fluorine-containing thioureido ligands
resolves10.1039/C4SC03094J
Metal complexes as potential modulators of inflammatory and autoimmune responses
resolves10.1039/c3sc51725j
Targeting the endoplasmic reticulum with a membrane-interactive luminescent ruthenium(ii) polypyridyl complex
resolves10.1039/C5SC01381J
Terpyridine–Cu( <scp>ii</scp> ) targeting human telomeric DNA to produce highly stereospecific G-quadruplex DNA metalloenzyme
resolves10.1039/C3SC53317D
Metal-catalyzed uncaging of DNA-binding agents in living cells
resolves10.1039/C5SC04514B
Direct observation by time-resolved infrared spectroscopy of the bright and the dark excited states of the [Ru(phen) <sub>2</sub> (dppz)] <sup>2+</sup> light-switch compound in solution and when bound to DNA
resolves10.1016/j.mrfmmm.2007.03.008
Noncovalent interactions with DNA: An overview
resolves10.1016/S1452-3981(23)15101-7
Investigation of the Electrochemical Interaction Behavior of DNA with 5-Fluorouracil Derivatives
resolves10.1016/S1452-3981(23)15014-0
In Vitro Study of DNA Interaction with Trichlorobenzenes by Spectroscopic and Voltammetric Techniques
resolves10.1016/j.cbi.2009.12.029
The role of DNA repair in benzene-induced carcinogenesis
resolves10.1089/dna.2008.0740
<i>In Vitro</i> Study of DNA Interaction with Clodinafop-Propargyl Herbicide
resolves10.1089/dna.2009.0892
<i>In Vitro</i> Study of Damaging Effects of 2,4-Dichlorophenoxyacetic Acid on DNA Structure by Spectroscopic and Voltammetric Techniques
resolves10.1016/j.bpc.2004.06.009
Fluorometric investigation of interaction of 3-acetyl-4-oxo-6,7-dihydro-12H indolo-[2,3-a] quinolizine with bovine serum albumin
resolves10.1016/j.jpba.2005.11.037
Study of the interaction of an anticancer drug with human and bovine serum albumin: Spectroscopic approach
resolves10.1016/j.ijbiomac.2006.03.020
Studies on the interaction between Oxaprozin-E and bovine serum albumin by spectroscopic methods
resolves10.1016/S0065-3233(08)60640-3
Structure of Serum Albumin
resolves10.1016/S0065-7743(08)60472-8
Chapter 33. Plasma Protein Binding of Drugs
resolves10.2174/0929867023369673
Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance
resolves10.2298/JSC141028011J
Double catalytic effect of (PhNH3)2CuCl4 in a novel, highly efficient synthesis of 2-oxo and thioxo-1,2,3,4-tetra-hydopyrimidines
resolves10.1007/s11030-016-9658-y
Vanillic aldehydes for the one-pot synthesis of novel 2-oxo-1,2,3,4-tetrahydropyrimidines
resolves10.1039/C6RA07711K
Solvent-free synthesis of novel vanillidene derivatives of Meldrum's acid: biological evaluation, DNA and BSA binding study
resolves10.1039/B617186A
Complexation versus thiadiazole formation for reactions of thiosemicarbazides with copper( <scp>ii</scp> )
resolves10.3891/acta.chem.scand.28a-0194
The Crystal Structure of Anilinium Tetrachlorocuprate(II).
resolves10.1016/S0277-5387(98)00376-3
Syntheses and characterization of copper(II) complexes with Schiff-base ligands derived from ethylenediamine, diphenylethylenediamine and nitro, bromo and methoxy salicylaldehyde
resolves10.1016/S0010-8545(00)80135-6
The electronic properties and stereochemistry of mono-nuclear complexes of the copper(II) ion
resolves10.1016/0022-1902(81)80570-2
ESR study of Cu(II) complexes
resolves10.1093/glycob/11.3.25R
Formation of the glycan chains in the synthesis of bacterial peptidoglycan
resolves10.1007/BF02931327
Structure and biosynthesis of fungal cell walls: Methodological approaches
resolves10.1038/sj.neo.7900101
Cell Cycle and Apoptosis
resolves10.1021/bi00635a022
Mechanism of ethidium bromide fluorescence enhancement on binding to nucleic acids
resolves10.1021/bi00745a020
Quenching of fluorescence by oxygen. Probe for structural fluctuations in macromolecules
resolves10.15386/cjmed-357
Bovine serum albumin interactions with metal complexes
resolves10.1021/ja00071a005
Studies of the 2:1 chromomycin A3-Mg2+ complex in methanol: role of the carbohydrates in complex formation
resolves10.1016/j.bmcl.2013.05.016
Synthesis and neuroprotective effect of E-3,4-dihydroxy styryl aralkyl ketones derivatives against oxidative stress and inflammation
resolves10.1021/ic00065a020
Spectroscopic and photophysical studies of the binding interactions between copper phenanthroline complexes and RNA
resolves10.1007/978-1-4757-3061-6
Principles of Fluorescence Spectroscopy
resolves10.1107/S0108767307043930
A short history of<i>SHELX</i>
resolves10.1107/S0021889895007138
<i>PARST</i>95 – an update to <i>PARST</i>: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses
resolves10.1107/S0021889802022112
Single-crystal structure validation with the program<i>PLATON</i>
resolves10.1107/S002188980600731X
<i>Mercury</i>: visualization and analysis of crystal structures
resolves10.1016/j.ymeth.2007.01.006
Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals
resolves10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
The 5 references without a DOI — listed, not checked
no DOI — not checkedC6DT02257J-(cit3)/*[position()=1]
no DOI — not checkedC6DT02257J-(cit64)/*[position()=1]
no DOI — not checkedC6DT02257J-(cit71)/*[position()=1]
no DOI — not checkedC6DT02257J-(cit74)/*[position()=1]
no DOI — not checkedNCCLS (National Committee for Clinical Laboratory Standards) , Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-forming Filamentous Fungi: Proposed Standard M38-P. NCCLS, Wayne, PA, USA, 1998
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1039/c6dt02257j"><img src="https://citestamp.com/citestamped/10.1039/c6dt02257j/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1039/c6dt02257j/badge.svg)](https://citestamp.com/citestamped/10.1039/c6dt02257j)